A Guide to Fuzeon: The First Fusion InhibitorJanuary 2005 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! Consult your doctor! The only purpose of this booklet is to educate and to inform. It is no substitute for professional care by a doctor or other medical professionals. Body Health Resources Corporation neither endorses nor opposes any particular treatment option discussed in this booklet. Instead, we encourage you to discuss your options with a healthcare provider who specializes in treating HIV. We would like to thank David Wohl, M.D., for generously providing a medical review of this booklet. Funding for this booklet comes in part from educational grants provided by Roche Pharmaceuticals and Trimeris.
Copyright © 2005 Body Health Resources Corporation. All rights reserved. A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by The Body. It is a part of the publication A Guide to Fuzeon: The First Fusion Inhibitor.
|
|